“Mesa Biotech’s innovative platform will enable us to accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care,” says Thermo Fisher Scientific’s Mark Stevenson.
Read More
Under the program, Mammoth will leverage its robust DETECTR platform for CRISPR-based diagnostics to detect emerging biological threats.
Read More
A high-throughput test that can predict neutralizing activities is a critical step toward understanding herd immunity to covid-19.
Read More
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read More
With Concentriq, LabPON gains added flexibility to scale its routine digital pathology operations as the total number of worldwide cancer cases continues to rise.
Read More